liu.seSearch for publications in DiVA
Change search
Link to record
Permanent link

Direct link
BETA
Bruhn, Sören
Publications (10 of 13) Show all publications
Bruhn, S., Fang, Y., Barrenäs, F., Gustafsson, M., Zhang, H., Konstantinell, A., . . . Benson, M. (2014). A Generally Applicable Translational Strategy Identifies S100A4 as a Candidate Gene in Allergy. Science Translational Medicine, 6(218).
Open this publication in new window or tab >>A Generally Applicable Translational Strategy Identifies S100A4 as a Candidate Gene in Allergy
Show others...
2014 (English)In: Science Translational Medicine, ISSN 1946-6234, E-ISSN 1946-6242, Vol. 6, no 218Article in journal (Refereed) Published
Abstract [en]

The identification of diagnostic markers and therapeutic candidate genes in common diseases is complicated by the involvement of thousands of genes. We hypothesized that genes co-regulated with a key gene in allergy, IL13, would form a module that could help to identify candidate genes. We identified a T helper 2 (T(H)2) cell module by small interfering RNA-mediated knockdown of 25 putative IL13-regulating transcription factors followed by expression profiling. The module contained candidate genes whose diagnostic potential was supported by clinical studies. Functional studies of human TH2 cells as well as mouse models of allergy showed that deletion of one of the genes, S100A4, resulted in decreased signs of allergy including TH2 cell activation, humoral immunity, and infiltration of effector cells. Specifically, dendritic cells required S100A4 for activating T cells. Treatment with an anti-S100A4 antibody resulted in decreased signs of allergy in the mouse model as well as in allergen-challenged T cells from allergic patients. This strategy, which may be generally applicable to complex diseases, identified and validated an important diagnostic and therapeutic candidate gene in allergy.

Place, publisher, year, edition, pages
American Association for the Advancement of Science, 2014
National Category
Clinical Medicine Basic Medicine
Identifiers
urn:nbn:se:liu:diva-104118 (URN)10.1126/scitranslmed.3007410 (DOI)000329789600003 ()
Available from: 2014-02-07 Created: 2014-02-07 Last updated: 2018-01-11
Nestor, C., Barrenäs, F., Wang, H., Lentini, A., Zhang, H., Bruhn, S., . . . Benson, M. (2014). DNA Methylation Changes Separate Allergic Patients from Healthy Controls and May Reflect Altered CD4(+) T-Cell Population Structure. PLoS Genetics, 10(1), e1004059.
Open this publication in new window or tab >>DNA Methylation Changes Separate Allergic Patients from Healthy Controls and May Reflect Altered CD4(+) T-Cell Population Structure
Show others...
2014 (English)In: PLoS Genetics, ISSN 1553-7390, E-ISSN 1553-7404, Vol. 10, no 1, e1004059- p.Article in journal (Refereed) Published
Abstract [en]

Altered DNA methylation patterns in CD4(+) T-cells indicate the importance of epigenetic mechanisms in inflammatory diseases. However, the identification of these alterations is complicated by the heterogeneity of most inflammatory diseases. Seasonal allergic rhinitis (SAR) is an optimal disease model for the study of DNA methylation because of its welldefined phenotype and etiology. We generated genome-wide DNA methylation (N-patients = 8, N-controls = 8) and gene expression (N-patients = 9, N-controls = 10) profiles of CD4(+) T-cells from SAR patients and healthy controls using Illuminas HumanMethylation450 and HT-12 microarrays, respectively. DNA methylation profiles clearly and robustly distinguished SAR patients from controls, during and outside the pollen season. In agreement with previously published studies, gene expression profiles of the same samples failed to separate patients and controls. Separation by methylation (N-patients = 12, N-controls = 12), but not by gene expression (N-patients = 21, N-controls = 21) was also observed in an in vitro model system in which purified PBMCs from patients and healthy controls were challenged with allergen. We observed changes in the proportions of memory T-cell populations between patients (N-patients = 35) and controls (N-controls = 12), which could explain the observed difference in DNA methylation. Our data highlight the potential of epigenomics in the stratification of immune disease and represents the first successful molecular classification of SAR using CD4(+) T cells.

Place, publisher, year, edition, pages
Public Library of Science, 2014
National Category
Clinical Medicine Basic Medicine
Identifiers
urn:nbn:se:liu:diva-107871 (URN)10.1371/journal.pgen.1004059 (DOI)000336525000030 ()
Available from: 2014-06-23 Created: 2014-06-23 Last updated: 2018-01-11
Skogberg, G., Gudmundsdottir, J., van der Post, S., Sandstrom, K., Bruhn, S., Benson, M., . . . Ekwall, O. (2013). Characterization of Human Thymic Exosomes. PLoS ONE, 8(7).
Open this publication in new window or tab >>Characterization of Human Thymic Exosomes
Show others...
2013 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 8, no 7Article in journal (Refereed) Published
Abstract [en]

Exosomes are nanosized membrane-bound vesicles that are released by various cell types and are capable of carrying proteins, lipids and RNAs which can be delivered to recipient cells. Exosomes play a role in intercellular communication and have been described to mediate immunologic information. In this article we report the first isolation and characterization of exosomes from human thymic tissue. Using electron microscopy, particle size determination, density gradient measurement, flow cytometry, proteomic analysis and microRNA profiling we describe the morphology, size, density, protein composition and microRNA content of human thymic exosomes. The thymic exosomes share characteristics with previously described exosomes such as antigen presentation molecules, but they also exhibit thymus specific features regarding surface markers, protein content and microRNA profile. Interestingly, thymic exosomes carry proteins that have a tissue restricted expression in the periphery which may suggest a role in T cell selection and the induction of central tolerance. We speculate that thymic exosomes may provide the means for intercellular information exchange necessary for negative selection and regulatory T cell formation of the developing thymocytes within the human thymic medulla.

Place, publisher, year, edition, pages
Public Library of Science, 2013
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-95948 (URN)10.1371/journal.pone.0067554 (DOI)000321341000055 ()
Note

Funding Agencies|Swedish Research Council|80409601|Region Vastra Gotaland|ALFGBG-771712|AFA Forsakring|100258|IngaBritt and Arne Lundbergs Research Foundation||Gothenburg Medical Society||

Available from: 2013-08-19 Created: 2013-08-12 Last updated: 2017-12-06
Couto Alves, A., Bruhn, S., Ramasamy, A., Wang, H., Holloway, J. W., Hartikainen, A.-L., . . . Coin, L. J. (2013). Dysregulation of Complement System and CD4+T Cell Activation Pathways Implicated in Allergic Response. PLoS ONE, 8(10).
Open this publication in new window or tab >>Dysregulation of Complement System and CD4+T Cell Activation Pathways Implicated in Allergic Response
Show others...
2013 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 8, no 10Article in journal (Refereed) Published
Abstract [en]

Allergy is a complex disease that is likely to involve dysregulated CD4+ T cell activation. Here we propose a novel methodology to gain insight into how coordinated behaviour emerges between disease-dysregulated pathways in response to pathophysiological stimuli. Using peripheral blood mononuclear cells of allergic rhinitis patients and controls cultured with and without pollen allergens, we integrate CD4+ T cell gene expression from microarray data and genetic markers of allergic sensitisation from GWAS data at the pathway level using enrichment analysis; implicating the complement system in both cellular and systemic response to pollen allergens. We delineate a novel disease network linking T cell activation to the complement system that is significantly enriched for genes exhibiting correlated gene expression and protein-protein interactions, suggesting a tight biological coordination that is dysregulated in the disease state in response to pollen allergen but not to diluent. This novel disease network has high predictive power for the gene and protein expression of the Th2 cytokine profile (IL-4, IL-5, IL-10, IL-13) and of the Th2 master regulator (GATA3), suggesting its involvement in the early stages of CD4+ T cell differentiation. Dissection of the complement system gene expression identifies 7 genes specifically associated with atopic response to pollen, including C1QR1, CFD, CFP, ITGB2, ITGAX and confirms the role of C3AR1 and C5AR1. Two of these genes (ITGB2 and C3AR1) are also implicated in the network linking complement system to T cell activation, which comprises 6 differentially expressed genes. C3AR1 is also significantly associated with allergic sensitisation in GWAS data.

Place, publisher, year, edition, pages
Public Library of Science, 2013
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-100479 (URN)10.1371/journal.pone.0074821 (DOI)000325552200004 ()
Note

Funding Agencies|European Commission|223367|Academy of Finland (Centre of Excellence in Complex Disease Genetics and SALVE)|1047811203151292691114194139900/24300796|University Hospital Oulu||Biocenter||University of Oulu|75617|NHLBI through STAMPEED program|5R01HL087679-021RL1MH083268-01|NIH/NIMH|5R01MH63706:02|ENGAGE project|HEALTH-F4-2007-201413|Medical Research Council, UK (PrevMetSyn/SALVE)||Academy of Finland||Biocentrum Helsinki||

Available from: 2013-11-08 Created: 2013-11-08 Last updated: 2017-12-06
Chavali, S., Bruhn, S., Tiemann, K., Sætrom, P., Barrenäs, F., Saito, T., . . . Benson, M. (2013). MicroRNAs act complementarily to regulate disease-related mRNA modules in human diseases. RNA: A publication of the RNA Society, 19(11), 1552-1562.
Open this publication in new window or tab >>MicroRNAs act complementarily to regulate disease-related mRNA modules in human diseases
Show others...
2013 (English)In: RNA: A publication of the RNA Society, ISSN 1355-8382, E-ISSN 1469-9001, Vol. 19, no 11, 1552-1562 p.Article in journal (Refereed) Published
Abstract [en]

MicroRNAs (miRNAs) play a key role in regulating mRNA expression, and individual miRNAs have been proposed as diagnostic and therapeutic candidates. The identification of such candidates is complicated by the involvement of multiple miRNAs and mRNAs as well as unknown disease topology of the miRNAs. Here, we investigated if disease-associated miRNAs regulate modules of disease-associated mRNAs, if those miRNAs act complementarily or synergistically, and if single or combinations of miRNAs can be targeted to alter module functions. We first analyzed publicly available miRNA and mRNA expression data for five different diseases. Integrated target prediction and network-based analysis showed that the miRNAs regulated modules of disease-relevant genes. Most of the miRNAs acted complementarily to regulate multiple mRNAs. To functionally test these findings, we repeated the analysis using our own miRNA and mRNA expression data from CD4+ T cells from patients with seasonal allergic rhinitis. This is a good model of complex diseases because of its well-defined phenotype and pathogenesis. Combined computational and functional studies confirmed that miRNAs mainly acted complementarily and that a combination of two complementary miRNAs, miR-223 and miR-139-3p, could be targeted to alter disease-relevant module functions, namely, the release of type 2 helper T-cell (Th2) cytokines. Taken together, our findings indicate that miRNAs act complementarily to regulate modules of disease-related mRNAs and can be targeted to alter disease-relevant functions.

Place, publisher, year, edition, pages
Cold Spring Harbor Laboratory Press (CSHL), 2013
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-99867 (URN)10.1261/rna.038414.113 (DOI)000325813900010 ()24062574 (PubMedID)
Available from: 2013-10-22 Created: 2013-10-22 Last updated: 2017-12-06Bibliographically approved
Zhao, Y., Wang, H., Gustafsson, M., Muraro, A., Bruhn, S. & Benson, M. (2012). Combined Multivariate and Pathway Analyses Show That Allergen-Induced Gene Expression Changes in CD4(+) T Cells Are Reversed by Glucocorticoids. PLoS ONE, 7(6).
Open this publication in new window or tab >>Combined Multivariate and Pathway Analyses Show That Allergen-Induced Gene Expression Changes in CD4(+) T Cells Are Reversed by Glucocorticoids
Show others...
2012 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 7, no 6Article in journal (Refereed) Published
Abstract [en]

Background: Glucocorticoids (GCs) play a key role in the treatment of allergy. However, the genome-wide effects of GCs on gene expression in allergen-challenged CD4(+) T cells have not been described. The aim of this study was to perform a genome-wide analysis to investigate whether allergen-induced gene expression changes in CD4(+) T cells could be reversed by GCs. Methodology/Principal Findings: Gene expression microarray analysis was performed to profile gene expression in diluent( D), allergen- (A), and allergen + hydrocortisone- (T) challenged CD4(+) T cells from patients with seasonal allergic rhinitis. Principal component analysis (PCA) showed good separation of the three groups. To identify the correlation between changes in gene expression in allergen-challenged CD4(+) T cells before and after GC treatment, we performed orthogonal partial least squares discriminant analysis (OPLS-DA) followed by Pearson correlation analysis. This revealed that allergen-induced genes were widely reversed by GC treatment (r = -0.77, Pless than0.0001). We extracted 547 genes reversed by GC treatment from OPLS-DA models based on their high contribution to the discrimination and found that those genes belonged to several different inflammatory pathways including TNFR2 Signalling, Interferon Signalling, Glucocorticoid Receptor Signalling and T Helper Cell Differentiation. The results were supported by gene expression microarray analyses of two independent materials. Conclusions/Significance: Allergen-induced gene expression changes in CD4(+) T cells were reversed by treatment with glucocorticoids. The top allergen-induced genes that reversed by GC treatment belonged to several inflammatory pathways and genes of known or potential relevance for allergy.

Place, publisher, year, edition, pages
Public Library of Science, 2012
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-79798 (URN)10.1371/journal.pone.0039016 (DOI)000305340000060 ()
Available from: 2012-08-17 Created: 2012-08-14 Last updated: 2017-12-07Bibliographically approved
Bruhn, S., Katzenellenbogen, M., Gustafsson, M., Krönke, A., Sönnichsen, B., Zhang, H. & Benson, M. (2012). Combining gene expression microarray- and cluster analysis with sequence-based predictions to identify regulators of IL-13 in allergy. Cytokine, 60(3), 736-740.
Open this publication in new window or tab >>Combining gene expression microarray- and cluster analysis with sequence-based predictions to identify regulators of IL-13 in allergy
Show others...
2012 (English)In: Cytokine, ISSN 1043-4666, E-ISSN 1096-0023, Vol. 60, no 3, 736-740 p.Article in journal (Refereed) Published
Abstract [en]

The Th2 cytokine IL-13 plays a key role in allergy, by regulating IgE, airway hyper secretion, eosinophils and mast cells. In this study, we aimed to identify novel transcription factors (TFs) that potentially regulated IL-13. We analyzed Th2 polarized naïve T cells from four different blood donors with gene expression microarrays to find clusters of genes that were correlated or anti-correlated with IL13. These clusters were further filtered, by selecting genes that were functionally related. In these clusters, we identified three transcription factors (TFs) that were predicted to regulate the expression of IL13, namely CEBPB, E2F6 and AHR. siRNA mediated knockdowns of these TFs in naïve polarized T cells showed significant increases of IL13, following knockdown of CEBPB and E2F6, but not AHR. This suggested an inhibitory role of CEBPB and E2F6 in the regulation of IL13 and allergy. This was supported by analysis of E2F6, but not CEBPB, in allergen-challenged CD4+ T cells from six allergic patients and six healthy controls, which showed decreased expression of E2F6 in patients. In summary, our findings indicate an inhibitory role of E2F6 in the regulation of IL-13 and allergy. The analytical approach may be generally applicable to elucidate the complex regulatory patterns in Th2 cell polarization and allergy.

Place, publisher, year, edition, pages
Elsevier, 2012
Keyword
Allergy Interleukin-13 Transcription factor E2F6
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-81981 (URN)10.1016/j.cyto.2012.08.009 (DOI)000311248000022 ()
Note

funding agencies|European Commission|223367|Swedish Medical Research Council||

Available from: 2012-09-27 Created: 2012-09-27 Last updated: 2017-12-07
Barrenäs, F., Bruhn, S., Gustafsson, M., Jörnsten, R., Langston, M. A., Nestor, C., . . . Benson, M. (2012). Disease-Associated MRNA Expression Differences in Genes with Low DNA Methylation. .
Open this publication in new window or tab >>Disease-Associated MRNA Expression Differences in Genes with Low DNA Methylation
Show others...
2012 (English)Manuscript (preprint) (Other academic)
Abstract [en]

Although the importance of DNA methylation for mRNA expression has been shown for individualgenes in several complex diseases, such a relation has been difficult to show on a genome-wide scale.Here, we used microarrays to examine the relationship between DNA methylation and mRNAexpression in CD4+ T cells from patients with seasonal allergic rhinitis (SAR) and healthy controls.SAR is an optimal disease model because the disease process can be studied by comparing allergenchallengedCD4+ T cells obtained from patients and controls, and mimicked in Th2 polarised T cellsfrom healthy controls. The cells from patients can be analyzed to study relations between methylationand mRNA expression, while the Th2 cells can be used for functional studies. We found that DNAmethylation, but not mRNA expression clearly separated patients from controls. Similar to studies ofother complex diseases, we found no general relation between DNA methylation and mRNAexpression. However, when we took into account the absence or presence of CpG islands in thepromoters of disease associated genes an association was found: low methylation genes without CpGislands had significantly higher expression levels of disease-associated genes. This association wasconfirmed for genes whose expression levels were regulated by a transcription factor of knownrelevance for allergy, IRF4, using combined ChIP-chip and siRNA mediated silencing of IRF4expression. In summary, disease-associated increases of mRNA expression were found in lowmethylation genes without CpG islands in CD4+ T cells from patients with SAR. Further studies arewarranted to examine if a similar association is found in other complex diseases.

National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-81897 (URN)
Available from: 2012-09-24 Created: 2012-09-24 Last updated: 2012-09-24Bibliographically approved
Bruhn, S., Barrenäs, F., Mobini, R., Andersson, B. A., Chavali, S., Egan, B. S., . . . Benson, M. (2012). Increased expression of IRF4 and ETS1 in CD4+ cells from patients with intermittent allergic rhinitis. Allergy. European Journal of Allergy and Clinical Immunology, 67(1), 33-40.
Open this publication in new window or tab >>Increased expression of IRF4 and ETS1 in CD4+ cells from patients with intermittent allergic rhinitis
Show others...
2012 (English)In: Allergy. European Journal of Allergy and Clinical Immunology, ISSN 0105-4538, E-ISSN 1398-9995, Vol. 67, no 1, 33-40 p.Article in journal (Refereed) Published
Abstract [en]

Background: The transcription factor (TF) IRF4 is involved in the regulation of Th1, Th2, Th9, and Th17 cells, and animal studies have indicated an important role in allergy. However, IRF4 and its target genes have not been examined in human allergy. Methods: IRF4 and its target genes were examined in allergen-challenged CD4+ cells from patients with IAR, using combined gene expression microarrays and chromatin immunoprecipitation chips (ChIP-chips), computational target prediction, and RNAi knockdowns. Results: IRF4 increased in allergen-challenged CD4+ cells from patients with IAR, and functional studies supported its role in Th2 cell activation. IRF4 ChIP-chip showed that IRF4 regulated a large number of genes relevant to Th cell differentiation. However, neither Th1 nor Th2 cytokines were the direct targets of IRF4. To examine whether IRF4 induced Th2 cytokines via one or more downstream TFs, we combined gene expression microarrays, ChIP-chips, and computational target prediction and found a putative intermediary TF, namely ETS1 in allergen-challenged CD4+ cells from allergic patients. ETS1 increased significantly in allergen-challenged CD4+ cells from patients compared to controls. Gene expression microarrays before and after ETS1 RNAi knockdown showed that ETS1 induced Th2 cytokines as well as disease-related pathways. Conclusions: Increased expression of IRF4 in allergen-challenged CD4+ cells from patients with intermittent allergic rhinitis leads to activation of a complex transcriptional program, including Th2 cytokines.

Place, publisher, year, edition, pages
John Wiley and Sons, 2012
Keyword
Allergy, transcription factor
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-75112 (URN)10.1111/j.1398-9995.2011.02707.x (DOI)000297921100007 ()
Note
Funding Agencies|European Commission|223367|MultiMod||Swedish Medical Research Council||US National Institutes of Health|P01-DA-015027-01R01-MH-074460-01U01-AA-013512U01-AA-013641-04|US Department of Energy under the EPSCoR Laboratory||Available from: 2012-02-21 Created: 2012-02-17 Last updated: 2017-12-07
Schmid, F., Bruhn, S., Weber, K., Mitrücker, H. & Guse, A. (2011). CD38: a NAADP degrading enzyme. FEBS Letters, 585(22), 3544-3548.
Open this publication in new window or tab >>CD38: a NAADP degrading enzyme
Show others...
2011 (English)In: FEBS Letters, ISSN 0014-5793, E-ISSN 1873-3468, Vol. 585, no 22, 3544-3548 p.Article in journal (Refereed) Published
Abstract [en]

The role of the multifunctional enzyme CD38 in formation of the Ca2+-mobilizing second messenger nicotinic acid adenine dinucleotide phosphate (NAADP) was investigated. Gene silencing of CD38 did neither inhibit NAADP synthesis in intact Jurkat T cells nor in thymus or spleen obtained from CD38 knock out mice. In vitro, both NAADP formation by base-exchange and degradation to 2-phospho adenosine diphosphoribose were efficiently decreased. Thus in vivo CD38 appears to be a NAADPdegrading rather than a NAADP forming enzyme, perhaps avoiding desensitizing NAADP levels in intact cells.

Place, publisher, year, edition, pages
Elsevier, 2011
Keyword
Calcium signalling; NAADP; CD38; Jurkat T lymphocyte
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-81987 (URN)10.1016/j.febslet.2011.10.017 (DOI)
Available from: 2012-09-27 Created: 2012-09-27 Last updated: 2017-12-07
Organisations

Search in DiVA

Show all publications